NSCLC STAGE IIIB

Clinical trials for NSCLC STAGE IIIB explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Blood tests track lung cancer drug effectiveness

Disease control Ongoing

This study is testing how well the drug brigatinib works for people with advanced non-small cell lung cancer that has a specific genetic change (ALK+). Researchers will also explore if simple blood tests (liquid biopsies) can help track how the cancer responds to treatment over t…

Matched conditions: NSCLC STAGE IIIB

Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

NSCLC STAGE IIIB

Get alerted when new NSCLC STAGE IIIB trials appear

Blood tests track lung cancer drug effectiveness